| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/15/2001 | CN1069644C Novel silicone derivatives, their production and use |
| 08/15/2001 | CN1069521C Improvement of auxiliary material containing chlorohaxanpyridine acetate |
| 08/15/2001 | CN1069518C Oral medicine for reducing cholesterol |
| 08/14/2001 | US6275728 Thin polymer film drug reservoirs |
| 08/14/2001 | US6274727 Method for producing shaped and unshaped polyol masses |
| 08/14/2001 | US6274713 Suited to enhance images of selected mammalian organs, tissues, cells, and the like, in vivo, using magnetic resonance imaging, x-ray, gamma scintigraphy, and ct scanning |
| 08/14/2001 | US6274634 Aqueous suspension for eyes; mixture of fluorometholone and hydroxypropylmethyl cellulose |
| 08/14/2001 | US6274626 Administering a composition of pheniramine maleate and povidone dropwise into the eye to reduce redness, dryness, and itching |
| 08/14/2001 | US6274609 4-oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4h-1 -benzopyran or its hydrate and a surfactant |
| 08/14/2001 | US6274599 Cisapride extended release |
| 08/14/2001 | US6274592 Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid |
| 08/14/2001 | US6274564 Mixture or complex with lysine, arginine, glutamine, tyrosine, serine, threonine, and/or asparagine; vitamin b12 deficiency; nervous system, psychological, autoimmune disorders |
| 08/14/2001 | US6274555 Composition and method for topical animal medication |
| 08/14/2001 | US6274553 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
| 08/14/2001 | US6274548 Pectic substance as a growth factor stabilizer |
| 08/14/2001 | US6274343 Conjugate of delivery vehicle having ability to localize at neoplastic tissue and agent which increases blood supply to tissue; anticarcinogenic/antitumor agents; diagnostic imaging |
| 08/14/2001 | US6274331 Using recombinant dna vectors which encode di-alpha or di-beta globin-like polypeptide having linker, transforming cells, screening for production by determining response to carbon monoxide, determining amino acid sequence of linker |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274175 Prolonged release of GM-CSF |
| 08/14/2001 | US6274174 Aggregates of spherical multivalent metal alginate microparticles and methods of making them |
| 08/14/2001 | US6274166 Transdermal delivery system |
| 08/14/2001 | US6274165 Patch for controlled delivery of oestradiol or its pharmaceutically acceptable derivatives |
| 08/14/2001 | US6274164 Glass fiber chemical delivery system |
| 08/14/2001 | US6274155 As absorbent with skin healing properties when incorporated into diapers, feminine hygiene products, wound dressings, including both human and veterinary uses, as soft tissue augmentation medium when used in subdermal implants; cosmetics |
| 08/14/2001 | US6274149 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 08/14/2001 | US6274132 Applying to vagina and adnexa topical preparation selected from liquid solutions, suspensions, semi-solids, salves, creams, gels, and suppositories, preparation consisting of glycerine, hydroxyethyl cellulose, glucono delta lactone |
| 08/14/2001 | US6274124 Adding 1,2-pentanediol to cosmetic or dermatological active agent to improve water resistance |
| 08/14/2001 | US6274121 Superparamagnetic particles, process for their manufacture and use |
| 08/14/2001 | CA2088778C Transdermal contraceptive formulations, methods and devices |
| 08/14/2001 | CA2083754C Stable vitamin and/or carotenoid products in powder form, and the preparation thereof |
| 08/09/2001 | WO2001057144A1 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate |
| 08/09/2001 | WO2001057091A1 Soluble, chimeric transcription factors that enter cells to modulate cell differentiation and phenotype |
| 08/09/2001 | WO2001057069A2 Targeting peptides |
| 08/09/2001 | WO2001056613A2 Sterile water generator |
| 08/09/2001 | WO2001056611A1 Oral delivery of allergens in milk |
| 08/09/2001 | WO2001056610A1 Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant |
| 08/09/2001 | WO2001056576A1 Transdermal therapeutic system for the administration of zaleplon |
| 08/09/2001 | WO2001056575A1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| 08/09/2001 | WO2001056562A1 Stable emulsion compositions |
| 08/09/2001 | WO2001056559A1 Aqueous solution for treating degenerative or autoimmune diseases and as immunomodulatory agent |
| 08/09/2001 | WO2001056548A2 Liposomes composition produced by a dehydration-rehydration process |
| 08/09/2001 | WO2001056547A2 Preparation of aqueous clear solution dosage forms with bile acids |
| 08/09/2001 | WO2001056544A2 Shell-and-core dosage form approaching zero-order drug release |
| 08/09/2001 | WO2001056543A1 Osmotically-driven fluid dispenser and coating composition |
| 08/09/2001 | WO2001056534A1 Clear water-in-oil emulsions |
| 08/09/2001 | WO2001056406A1 Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 08/09/2001 | WO2001032596A8 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 08/09/2001 | WO2001021217A3 Method of treating cells of the prostate prophylactically or therapeutically |
| 08/09/2001 | WO2001019342A3 Pharmaceutical formulation of fluticasone propionate |
| 08/09/2001 | WO2001019337A3 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 08/09/2001 | WO2001002017A3 Erythropoietin conjugates with polyethylenglycol |
| 08/09/2001 | WO2001000241A3 Novel vector complexes and their use in gene therapy |
| 08/09/2001 | WO2000078364A3 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 08/09/2001 | WO2000078361A3 Methods of imaging and targeting tumor vasculature |
| 08/09/2001 | WO2000078272A3 Guerbet alcohols |
| 08/09/2001 | WO2000074729A3 Alpha or beta emitters to fragments in radioimmunotherapy |
| 08/09/2001 | WO2000074646A3 Novel liposomal vector complexes and their use in gene therapy |
| 08/09/2001 | WO2000067728A3 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| 08/09/2001 | WO2000066173A3 Targeting of infectious agents bearing host cell proteins |
| 08/09/2001 | WO2000062813A3 Cationic peg-lipids and methods of use |
| 08/09/2001 | WO2000055072A3 Aerosol metering valve |
| 08/09/2001 | WO2000045795A3 Topical sprays comprising a film forming composition |
| 08/09/2001 | WO2000015202A3 Topical application products |
| 08/09/2001 | US20010012885 Conjugate consisting of an active substance and a non-exogeneous native protein |
| 08/09/2001 | US20010012859 Incorporation of a C3-7 fatty acid, e.g., sorbic acid, improves the penetration of the beta-blocker, e.g., carteolol hydrochloride, into the eye and retention in the eye tissues; glaucoma; vision defects |
| 08/09/2001 | US20010012844 Quinazoline, nitrothiazole and indolinone based hydrophobic formulations for oral administration for treating cell proliferation disorder in a mammal |
| 08/09/2001 | US20010012837 Anti-ulcer composition |
| 08/09/2001 | US20010012522 Multilayer; shell, core |
| 08/09/2001 | US20010012520 Lamellar gels and methods for making and regulating |
| 08/09/2001 | US20010012518 Oral dosage |
| 08/09/2001 | EP1143950A3 Topical application products |
| 08/09/2001 | DE10004790A1 Plaster-form transdermal therapeutic system containing zaleplon, especially for use as hypnotic agent, providing safe and controlled drug delivery |
| 08/09/2001 | DE10003653A1 Vektorkonstrukte zur gentherapeutisch vermittelten Radioiodtherapie entdifferenzierter und medullärer Schilddrüsen-Karzinome sowie nicht-thyreoidaler Tumore und ihrer Metastasen Vector constructs for gene therapy mediated radioiodine therapy of medullary thyroid carcinoma and dedifferentiated and non-thyroidal tumors and their metastases |
| 08/09/2001 | DE10003493A1 Preparing complexes of cyclodextrin and coenzyme Q10, are useful for treating cardiac or degenerative diseases, by homogenizing starting materials with an input of energy |
| 08/09/2001 | CA2683185A1 Osmotically-driven fluid dispenser and coating composition |
| 08/09/2001 | CA2399294A1 Clear water-in-oil emulsions comprising reduced amounts of surfactant and glycol |
| 08/09/2001 | CA2399124A1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| 08/09/2001 | CA2399058A1 Targeting peptides |
| 08/09/2001 | CA2397799A1 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate |
| 08/09/2001 | CA2396782A1 Shell-and-core dosage form approaching zero-order drug release |
| 08/08/2001 | EP1121941A1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 08/08/2001 | EP1121940A1 Pharmaceutical compositions comprising an antibiotic and bromhexine, and process for their preparation |
| 08/08/2001 | EP1121933A1 Premixed alatrofloxacin injectable compositions |
| 08/08/2001 | EP1121931A1 Controlled release oral preparations of esculetin and its derivatives |
| 08/08/2001 | EP1121927A2 A composition causing different skin sensations |
| 08/08/2001 | EP1121456A1 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
| 08/08/2001 | EP1121449A1 Delivery system for porcine somatotropin |
| 08/08/2001 | EP1121425A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/08/2001 | EP1121424A1 A modified polypeptide with reduced immune response |
| 08/08/2001 | EP1121373A2 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 08/08/2001 | EP1121362A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 08/08/2001 | EP1121355A1 Quinoline derivatives and their use as antibacterial agents |
| 08/08/2001 | EP1121156A2 Polymer conjugates of interferon beta- 1a and their uses |
| 08/08/2001 | EP1121155A2 Site-directed dual pegylation of proteins |
| 08/08/2001 | EP1121154A2 Macromolecular active substance conjugates and a method for the production thereof |
| 08/08/2001 | EP1121153A1 Site-specific labeling of disulfide-containing targeting vectors |
| 08/08/2001 | EP1121145A1 Insulin preparations for pulmonary delivery containing menthol |
| 08/08/2001 | EP1121144A1 Stable concentrated insulin preparations for pulmonary delivery |
| 08/08/2001 | EP1121132A1 Method and compositions for increasing bone mass |
| 08/08/2001 | EP1121130A2 Zinc finger-reactive antimicrobial compounds |